FDA removes boxed warnings from menopausal hormone therapy
The agency's November 2025 action also brought the first generic conjugated estrogens approval in more than 30 years.
Health News
Reporting on guideline revisions, drug approvals, safety warnings and newly published studies affecting women's care, each traced to the source document.